The Red Dragon Conference is a voluntary study group for Asian development strategies and regulatory intelligence in the pharmaceutical industry cofounded by Mr. Tetsuomi Takano in October 2008, who was appointed as the Vice-Chairperson initially and has been promoted to the Chairperson since 2014.

On August 23rd in Osaka and August 30th, 2024 in Tokyo, we held the 30th Red Dragon Conference for two weeks in a row, where Mr. Tetsuomi Takano, the Chairperson of the Red Dragon Conference, gave a presentation titled “Update on Clinical Development and Regulatory for China” covering the following three contents.

Contents
1.  CDE Annual Reports 2023 (Released on Feb. 4 and May 20, 2024)
2.  China’s update in the pharmaceutical industry/authorities/academia (Dec. 2023 through Aug. 2024)
3.  Japan Session at Global Clinical Development Summit, China BioWeek (Aug. 9, 2024, Shanghai)